Targeted Cellular Treatment of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease affecting all organ systems. The disease preferentially affects females of childbearing age. It runs a variable course. It may run a mild course that may never lead to severe disease and manifestations from critical organ systems. H...
Saved in:
| Main Authors: | Panagiotis Athanassiou, Lambros Athanassiou, Ifigenia Kostoglou-Athanassiou, Yehuda Shoenfeld |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/3/210 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating B Lymphocyte Subsets in Patients with Systemic Lupus Erythematosus
by: Joanna Kosałka-Węgiel, et al.
Published: (2024-12-01) -
Features of B cell subsets in primary Sjogren’s syndrome and systemic lupus erythematosus
by: S. S. Benevolenskaya, et al.
Published: (2024-11-01) -
Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus
by: Xiaowei Chen, et al.
Published: (2025-06-01) -
DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2016-07-01) -
Therapeutic effects of extracellular vesicles derived from mesenchymal stem cells primed with disease-conditioned-immune cells in systemic lupus erythematosus
by: Eun Wha Choi, et al.
Published: (2024-11-01)